Announcements Trials
Browse Landscape

Status

Completed 331Active not recruiting 134Terminated 110Recruiting 105Unknown 39Withdrawn 32Not yet recruiting 15Suspended 3No longer available 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Expanded_access 3

Sponsor

Cancer Type

Dermatologic 2CNS 1

Conditions

Melanoma 2Glioma 1Glioblastoma 1

Interventions

trametinib 4nilotinib 4elotuzumab 4dabrafenib 4Amifampridine 4regorafenib 3pembrolizumab 3midostaurin 3fludarabine phosphate 3fludarabine 3Nivolumab 3Lenalidomide 3Ipilimumab 3Everolimus 3Dexamethasone 3Cyclophosphamide 3Crizotinib 3Bortezomib 3Axitinib 3venetoclax 2veliparib 2tazemetostat 2talimogene laherparepvec 2navitoclax 2gallium 68 PSMA-11 2ceritinib 2carbon-11 acetate 2aldesleukin 2Whole-Body Irradiation 2Trabectedin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
No longer available × Ipilimumab × Clear all
NCT03460782 2019-11-08

An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas

Center Trials & Treatment

No longer available
CNS

Glioblastoma, Glioma

NCT02186249 2017-02-08

CheckMate218

Bristol-Myers Squibb

No longer available
Dermatologic

Melanoma

NCT00495066 2013-06-03

Compassionate Use Trial for Unresectable Melanoma With Ipilimumab

Bristol-Myers Squibb

No longer available
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡